XPH ETF
State Street SPDR S&P Pharmaceuticals ETF
XPH ETF Overview
XPH ETF (State Street SPDR S&P Pharmaceuticals ETF) is managed by State Street Investment Management with $540.6M in net assets. XPH expense ratio is 0.35%, holding 64 positions across sectors including Health Care, Consumer Staples, Financials. Inception date: 2006-06-19.
XPH performance shows a YTD return of 26.34%. The 1-year return is 50.94% and the 5-year return is 10.58%. XPH dividend yield stands at 0.47%, paid quarterly.
XPH top holdings include Amylyx Pharmaceuticals Inc (3.8%), Mbx Biosciences Inc (3.1%), Omeros Corp Com (2.9%), Definium Therapeutics, Inc. Common Shares (2.7%), Enliven Therapeutics Inc (2.4%). Go to all XPH holdings, XPH sectors, or XPH dividends.
XPH can be compared against other funds. Use XPH overlap to find shared positions, or XPH vs another fund for a side-by-side view. XPH alternatives are available via the screener, along with tax-loss harvesting opportunities.